Form 4 for BIIB Biogen
Accepted 2025-07-16 00:00:00 ET · period of report 2025-07-08 · accession 0001127602-25-019295 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-16 | 2025-07-08 | BIIB | Izzar Rachid | Head of Gbl Product Strat | S - Sale | $135.00 | -2,223 | 6,330 | -26% | -$300.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-08 | S | D | 2,223 | $135.00 | 6,330 | D | — | — |